Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery

July 15, 2024 updated by: Hao Long

Effects of Music Therapy on Perioperative Anxiety and Pain Management in Lung Surgery: A Randomized, Prospective, Multidisciplinary Trial

To explore the feasibility and effectiveness of Perioperative Music Therapy Plus Oxycodone in pain management after thoracic surgery, patients will be randomly assigned into two groups. The experimental group will receive perioperative music therapy and the control group will not. We will record and contrast the postoperative oxycodone usage to evaluate the effect of music therapy in relieving the pain. We will also use visual analogue scale, questionnaire and EEG to evaluate patients' anxiety and depression.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Sun Yat-sen University Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Enhanced CT or PET/CT indicate primary malignant pulmonary nodule;
  • The clinical stage belongs to cT1-4N0-2M0 before treatment or ycT1-4N0-2M0 after neoadjuvant treatment (AJCC/TNM 8th Edition);
  • Suitable for video-assisted thoracoscopic surgery after evaluated by thoracic surgeon;
  • FEV1 > 1.5L and DLCO > 60% pred;
  • Hearing loss lesser than 35 decibels (dB) in the better hearing ear;
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2;
  • American Society of Anesthesiologists Score of 1 or 2;
  • Confirmed eligibility for R0 resection for curative intent by thoracic surgeon assessment;
  • Adequate cardiopulmonary function, confirmed to meet the requirement for surgical resection for curative intent;
  • Able to provide written informed consent and able to understand and agree to comply with study requirements and evaluation forms;
  • Life expectancy greater than 12 months

Exclusion Criteria:

  • Enhanced CT or PET/CT indicate metastatic malignant pulmonary nodule;
  • Hearing loss greater than 35 decibels (dB) in the better hearing ear;
  • Active autoimmune disease or history of autoimmune disease that may recur; Note: well-controlled type 1 diabetes is allowed; hypothyroidism (controlled with thyroid hormone replacement only); well-controlled celiac disease; skin disease not requiring systemic treatment (eg, vitiligo, psoriasis, alopecia); any other condition that is not expected to recur in the absence of an external trigger.
  • History of interstitial lung disease, pneumonitis or uncontrolled systemic diseases, including diabetes, hypertension, pulmonary fibrosis, acute lung disease;
  • Serious infection occurred before grouping, including but not limited to hospitalization due to infectious complications, bacteremia or severe pneumonia; severe chronic or active infection (including pulmonary tuberculosis infection, etc.) requiring systemic (oral or intravenous) antibiotics within 14 days before grouping;
  • Simultaneous participation in another therapeutic clinical study;
  • Pregnant or lactating women, or male and female patients planning to have children during the study;
  • Other conditions that the investigators consider inappropriate for participation in this trial, such as poor compliance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oxycodone with Perioperative Music Therapy
Using perioperative music therapy plus oxycodone to manage the postoperative pain
Music therapist will play customized music in the perioperative period on the basis of oxycodone analgesia
No Intervention: Oxycodone without Perioperative Music Therapy
Using oxycodone only to manage the postoperative pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total dose of oxycodone within 48 hours after surgery
Time Frame: 48 hours after surgery
The total dose of oxycodone within 48 hours after surgery
48 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The kind and usage of anesthetics for anesthesia induction and maintenance
Time Frame: During the surgery
The kind and usage of anesthetics for anesthesia induction and maintenance, such as Propofol, Sufentanil and Cisatracurium
During the surgery
The VSA-A Score
Time Frame: From 1 day before surgery to the third day after surgery
The Visual Analogue Scale-Anxiety Score at different observation point
From 1 day before surgery to the third day after surgery
The VSA-P Score
Time Frame: From the first day to the third day after surgery
The Visual Analogue Scale-Pain Score at different observation point
From the first day to the third day after surgery
The incidence rate of analgesic related adverse reaction
Time Frame: 48 hours after surgery
The incidence rate of analgesic related adverse reaction within 72 hours after surgery
48 hours after surgery
The usage of extra analgesics after surgery
Time Frame: 48 hours after surgery
The usage of extra analgesics after surgery, such as Parecoxib, Tramadol or Morphine
48 hours after surgery
The quality of life after treatment
Time Frame: The third day after surgery
The quality of life assessed by questionnaire on the third day after surgery
The third day after surgery
The press times of PCIA pump within 48 hours after surgery
Time Frame: 48 hours after surgery
The press times of PCIA pump within 48 hours after surgery
48 hours after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of resting beta power of electroencephalography in the central brain areas by preoperative treatment
Time Frame: 1 hour before surgery
Changes of resting beta power of electroencephalography in the central brain areas by preoperative treatment
1 hour before surgery
Changes of resting beta power of electroencephalography in the frontal midline brain areas by preoperative treatment
Time Frame: 1 hour before surgery
Changes of resting beta power of electroencephalography in the frontal midline brain areas by preoperative treatment
1 hour before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

January 20, 2024

Study Completion (Actual)

April 20, 2024

Study Registration Dates

First Submitted

July 31, 2023

First Submitted That Met QC Criteria

July 31, 2023

First Posted (Actual)

August 8, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2024

Last Update Submitted That Met QC Criteria

July 15, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Perioperative Music Therapy

Subscribe